News
As more people take GLP-1 medications for weight loss, dietitians are seeing their appointments booked out for months.
In a recent conversation with Managed Healthcare Executive, Geoffrey Rutledge, M.D., of HealthTap, warned that the narrative ...
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep medicine.
Pharmaceutical company Novo Nordisk is waiting on federal approval to sell its blockbuster GLP-1 weight-loss treatment as a ...
Effective July 1, 2025, CVS Caremark will place Wegovy injection 2.4 mg as preferred on its commercial template formularies.
Health and wellness influencer Janelle Rohner had been documenting her weight loss journey long before she admitted to using a GLP-1 to help her progress. The nurse initially kickstarted her ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results